archive-org.com » ORG » S » SCIENCEMAG.ORG

Total: 698

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Effects of obesity on hormonally driven cancer in women | Science Translational Medicine
    Log in to view full text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 8 Issue 323 27 January 2016 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Effects of obesity on hormonally driven cancer in women Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Effects of obesity on hormonally driven cancer in women By Kelle H Moley Graham A Colditz Science Translational Medicine 27 Jan 2016 323ps3 Studies are starting to reveal the mechanisms for cancer risk resulting from obesity in women and their offspring Citation Manager Formats BibTeX Bookends EasyBib EndNote tagged EndNote 8 xml Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Share Effects of obesity on hormonally driven cancer

    Original URL path: http://stm.sciencemag.org/content/8/323/323ps3.full (2016-02-10)
    Open archived version from archive


  • Hyaluronan in adipose tissue: Beyond dermal filler and therapeutic carrier | Science Translational Medicine
    Center Dallas TX 75390 USA Department of Cell Biology University of Texas Southwestern Medical Center Dallas TX 75390 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF You are currently viewing the abstract View Full Text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Abstract Adipose hyaluronan is increasingly recognized as an active player in adipose tissue fibrosis and metabolic dysfunction However this role poses as many challenges as opportunities for therapeutic targeting of adipose tissue dysfunction during nutrient oversupply Copyright 2016 American Association for the Advancement of Science View Full Text Science Translational Medicine Vol 8 Issue 323 27 January 2016 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Hyaluronan in adipose tissue Beyond dermal filler and therapeutic carrier Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in

    Original URL path: http://stm.sciencemag.org/content/8/323/323ps4 (2016-02-10)
    Open archived version from archive

  • Hyaluronan in adipose tissue: Beyond dermal filler and therapeutic carrier | Science Translational Medicine
    USA Department of Cell Biology University of Texas Southwestern Medical Center Dallas TX 75390 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF Log in to view full text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 8 Issue 323 27 January 2016 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Hyaluronan in adipose tissue Beyond dermal filler and therapeutic carrier Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought you would like to see this page from the Science Translational Medicine web site Your Personal Message Send Message Download Powerpoint Print Save to my folders User Name Password Remember my user name password Submit Alerts Please log in to add an alert for this article Username Enter your Sciencemag org username Password Enter the password that accompanies your username Log in Request Permissions Citation tools Hyaluronan in adipose tissue Beyond dermal filler and therapeutic carrier By Yi Zhu Clair Crewe Philipp E Scherer Science Translational Medicine 27 Jan 2016 323ps4 Adipose hyaluronan may

    Original URL path: http://stm.sciencemag.org/content/8/323/323ps4.full (2016-02-10)
    Open archived version from archive

  • Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans | Science Translational Medicine
    PubMed Search for this author on this site Stephen Holleran Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rajasekhar Ramakrishnan Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert S Mittleman Sanofi Genzyme 500 Kendall Street Cambridge MA 02142 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Henry N Ginsberg Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF You are currently viewing the abstract View Full Text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Making sense of antisense Mipomersen is an FDA approved antisense oligonucleotide that lowers low density lipoprotein LDL in patients with high cholesterol by targeting apolipoprotein B apoB synthesis Although safe how mipomersen works exactly in humans is unclear Reyes Soffer and colleagues found in healthy volunteers that the drug reduced levels of LDL and its precursor very low density lipoproteins VLDL by increasing clearance of both of these vessel clogging lipoproteins rather than reducing their secretion from the liver The direct clearance of VLDL led to reduced production of LDL Studies in mice and cell lines demonstrated how the liver compensates for reduced apoB synthesis to potentially avoid hepatic steatosis Abstract Mipomersen is a 20mer antisense oligonucleotide ASO that inhibits apolipoprotein B apoB synthesis its low density lipoprotein LDL lowering effects should therefore result from reduced secretion of very low density lipoprotein VLDL We enrolled 17 healthy volunteers who received placebo injections weekly for 3 weeks followed by mipomersen weekly for 7 to 9 weeks Stable isotopes were used after each treatment to determine fractional catabolic rates and production rates of apoB in VLDL IDL intermediate density lipoprotein and LDL and of triglycerides in VLDL Mipomersen significantly reduced apoB in VLDL IDL and LDL which was associated with increases in fractional catabolic rates of VLDL and LDL apoB and reductions in production rates of IDL and LDL apoB Unexpectedly the production rates of VLDL apoB and VLDL triglycerides were unaffected Small interfering RNA mediated knockdown of apoB expression in human liver cells demonstrated preservation of apoB secretion across a range of apoB synthesis Titrated ASO knockdown of apoB mRNA in chow fed mice preserved both apoB and triglyceride secretion In contrast titrated ASO knockdown of apoB mRNA in high fat fed mice resulted in stepwise reductions in both

    Original URL path: http://stm.sciencemag.org/content/8/323/323ra12 (2016-02-10)
    Open archived version from archive

  • Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans | Science Translational Medicine
    Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nelson Fontanez Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel S Donovan Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wahida Karmally Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stephen Holleran Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rajasekhar Ramakrishnan Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert S Mittleman Sanofi Genzyme 500 Kendall Street Cambridge MA 02142 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Henry N Ginsberg Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF You are currently viewing the editor s summary View Full Text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Making sense of antisense Mipomersen is an FDA approved antisense oligonucleotide that lowers low density lipoprotein LDL in patients with high cholesterol by targeting apolipoprotein B apoB synthesis Although safe how mipomersen works exactly in humans is unclear Reyes Soffer and colleagues found in healthy volunteers that the drug reduced levels of LDL and its precursor very low density lipoproteins VLDL by increasing clearance of both of these vessel clogging lipoproteins rather than reducing their secretion from the liver The direct clearance of VLDL led to reduced production of LDL Studies in mice and cell lines demonstrated how the liver compensates for reduced apoB synthesis to potentially avoid hepatic steatosis Copyright 2016 American Association for the Advancement of Science Science Translational Medicine Vol 8 Issue 323 27 January 2016 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to

    Original URL path: http://stm.sciencemag.org/content/8/323/323ra12.editor-summary (2016-02-10)
    Open archived version from archive

  • Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans | Science Translational Medicine
    Search for this author on this site Tiffany Thomas Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Colleen Ngai Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nelson Fontanez Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel S Donovan Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wahida Karmally Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stephen Holleran Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rajasekhar Ramakrishnan Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert S Mittleman Sanofi Genzyme 500 Kendall Street Cambridge MA 02142 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Henry N Ginsberg Columbia University College of Physicians and Surgeons 630 West 168th Street New York NY 10032 USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures Data Info Metrics eLetters PDF Log in to view full text Username Enter your Sciencemag org username Password Enter the password that accompanies your username Forgot your username or password Log in Join Subscribe Purchase Article Activate Member Account Renew Subscription Recommend a subscription to your library Help for librarians Science Translational Medicine Vol 8 Issue 323 27 January 2016 Table of Contents Article Tools Email Thank you for your interest in spreading the word about Science Translational Medicine NOTE We only request your email address so that the person you are recommending the page to knows that you wanted them to see it and that it is not junk mail We do not capture any email address Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas You are going to email the following Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans Message Subject Your Name has forwarded a page to you from Science Translational Medicine Message Body Your Name thought

    Original URL path: http://stm.sciencemag.org/content/8/323/323ra12.full (2016-02-10)
    Open archived version from archive

  • USF1 deficiency activates brown adipose tissue and improves cardiometabolic health | Science Translational Medicine
    Kettunen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Institute for Molecular Medicine Finland FIMM Helsinki FI 00251 Finland Computational Medicine Institute of Health Sciences University of Oulu and Oulu University Hospital Oulu FI 90014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emmi Tikkanen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Institute for Molecular Medicine Finland FIMM Helsinki FI 00251 Finland Hjelt Institute University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tuula Manninen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Molecular Neurology Research Programs Unit University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jari Metso Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Reija Silvennoinen Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Krista Merikanto Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Maija Ruuth Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Julia Perttilä Minerva Foundation Institute for Medical Research Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anne Mäkelä Faculty of Biochemistry and Molecular Medicine University of Oulu Oulu FI 90014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ayaka Isomi Hiroshima University Hiroshima 730 0053 Japan Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anita M Tuomainen Institute of Dentistry University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anna Tikka Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Usama Abo Ramadan Experimental MRI Laboratory Department of Neurology Helsinki University Central Hospital Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ilkka Seppälä Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Terho Lehtimäki Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Johan Eriksson Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Folkhälsan Research Centre Helsinki FI 00251 Finland Unit of General Practice Helsinki University Central Hospital Helsinki FI 00290 Finland Department of General Practice and Primary Health Care University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aki Havulinna Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Antti Jula Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Pekka J Karhunen Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Veikko Salomaa Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Markus Perola Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christian Ehnholm Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Miriam Lee Rueckert Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Miranda Van Eck Department of Endocrinology and Metabolic Diseases Leiden University Medical Center Leiden 2333 ZA Netherlands Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anne Roivainen Turku PET Centre University of Turku and Turku University Hospital Turku FI 20520 Finland Turku Center for Disease Modeling University of Turku Turku FI 20520 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marja Riitta Taskinen Diabetes and Obesity Research Program University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Leena Peltonen Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eero Mervaala Institute of Biomedicine University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for

    Original URL path: http://stm.sciencemag.org/content/8/323/323ra13.editor-summary (2016-02-10)
    Open archived version from archive

  • USF1 deficiency activates brown adipose tissue and improves cardiometabolic health | Science Translational Medicine
    Scholar Find this author on PubMed Search for this author on this site Antti Pekka Sarin Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Institute for Molecular Medicine Finland FIMM Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Johannes Kettunen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Institute for Molecular Medicine Finland FIMM Helsinki FI 00251 Finland Computational Medicine Institute of Health Sciences University of Oulu and Oulu University Hospital Oulu FI 90014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emmi Tikkanen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Institute for Molecular Medicine Finland FIMM Helsinki FI 00251 Finland Hjelt Institute University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tuula Manninen Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Molecular Neurology Research Programs Unit University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jari Metso Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Reija Silvennoinen Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Krista Merikanto Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Maija Ruuth Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Julia Perttilä Minerva Foundation Institute for Medical Research Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anne Mäkelä Faculty of Biochemistry and Molecular Medicine University of Oulu Oulu FI 90014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ayaka Isomi Hiroshima University Hiroshima 730 0053 Japan Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anita M Tuomainen Institute of Dentistry University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anna Tikka Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Usama Abo Ramadan Experimental MRI Laboratory Department of Neurology Helsinki University Central Hospital Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ilkka Seppälä Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Terho Lehtimäki Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Johan Eriksson Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Folkhälsan Research Centre Helsinki FI 00251 Finland Unit of General Practice Helsinki University Central Hospital Helsinki FI 00290 Finland Department of General Practice and Primary Health Care University of Helsinki Helsinki FI 00014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aki Havulinna Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Antti Jula Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Pekka J Karhunen Department of Clinical Chemistry Fimlab Laboratories and Tampere University School of Medicine Tampere FI 33014 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Veikko Salomaa Department of Health National Institute for Health and Welfare Helsinki FI 00271 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Markus Perola Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christian Ehnholm Genomics and Biomarkers Unit National Institute for Health and Welfare Helsinki FI 00251 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Miriam Lee Rueckert Wihuri Research Institute Helsinki FI 00290 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Miranda Van Eck Department of Endocrinology and Metabolic Diseases Leiden University Medical Center Leiden 2333 ZA Netherlands Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anne Roivainen Turku PET Centre University of Turku and Turku University Hospital Turku FI 20520 Finland Turku Center for Disease Modeling University of Turku Turku FI 20520 Finland Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marja Riitta Taskinen Diabetes and Obesity Research Program University of Helsinki Helsinki FI 00014 Finland Find this author on

    Original URL path: http://stm.sciencemag.org/content/8/323/323ra13.full (2016-02-10)
    Open archived version from archive



  •